News

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...

According to IBM's latest predictions, medical device labs-on-a-chip will serve as health detectives for tracing disease at the nanoscale. In the next five years, new medical device labs-on-a-chip will serve as nanotechnology health detectives – tracing...

Type 2 diabetes has escalated to epidemic and financially catastrophic proportions, and is expected to affect one in three US adults by 2050. We already have more than 29 million diabetics in this country today; 28% remain undiagnosed. With the well-established...

Dental patients with severe periodontitis may have undiagnosed type 2 diabetes, Dutch researchers have discovered in a study that suggests targeted screening of individuals with worse gum disease could be a feasible way of picking up cases of diabetes at...

…. Clara Camaschella, MD, Deputy Director Division of Genetics and Cell Biology, Head of the Unit “Regulation of iron metabolism”, Professor of Internal Medicine, University hospital San Raffaele Milan, Italy; Anders Larsson, MD, PhD, Professor, Section of...

dianax is pleased to announce the first members of its newly formed Clinical Advisory Board ("CAB"). The CAB, comprising key thought leaders in point of need testing and subject matter experts in diabetes and iron metabolism therapy management will provide...

HbA1c may be the most effective method to identify patients with undiagnosed prediabetes and diabetes, and point-of-care testing further enhances that screening ability in primary-care settings, new research suggests. The findings were published...

Eugenio Iannone, Dianax Founder and seminal book author of Labs on Chip: Principles, Design & Technology explains: “Miniaturization is one of the key technology that have changed the human life in the last decades, allowing to pack a huge number of...

One step closer to industrialization … dianax announces successful transfer of its BioMEMS chip technology to Silex Microsystems which will industrialize the present prototype and can produce the chip up to a volume of several million pieces a year. Silex...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...

dianax was present at American Diabetes Association 2017 meeting in San Diego – USA to develop the network and initiate partnerships and alliances for the market introduction of its own Diabetes - A1c application. The Diabetes Care industry is living a...